# THE "FRAWLEY PROPOSAL" CAMPAIGN, 1966–1972 — a fully-cited reconstruction

*Built from a deep read of 67 ToxicDocs files held locally in `./toxicdocs/` (records in
`_campaign_records.json`). These are internal files of the plastics/chemical industry — chiefly
**Allied Chemical** (tagged "Allied Signal"), the **Society of the Plastics Industry (SPI)**, and the
**Manufacturing Chemists' Association (MCA)** — produced in vinyl-chloride/PVC litigation. **48 of the 67
are "core."** Each claim below cites a local file (by its `__hash` tail) + the document's own date; many
carry Allied's Bates stamps (`ASI-PR …`). Verbatim quotes are kept under 25 words.*

> **The headline this episode adds to the dossier:** Frawley's de minimis idea was not a lone proposal
> the FDA happened to weigh — it was the banner of a **coordinated, multi-association, lawyer-run
> industry campaign (1966–72)** to write a self-exempting threshold into FDA food-packaging law. And the
> campaign's own committee was **chaired by a Hercules man (Robert M. Miller)** — Frawley's employer.

---

## 1. The machinery and the cast
- **Vehicle:** the **SPI Food, Drug and Cosmetic Packaging Materials Committee** (founded 1936), and in
  parallel the **MCA Food, Drug and Cosmetic Chemicals Committee.**
- **Chairman:** **Robert M. Miller, Hercules, Inc.** (Delaware Trust Bldg., Wilmington — Frawley's own
  building) [`…qL0ea`, 1968-11-07; `…2NB`]. Vice-chair **Taylor W. Hanavan, DuPont**; committee founder/
  ex-chair **George W. Ingle, Monsanto.**
- **Counsel & quarterback:** **Keller and Heckman** — **Jerome H. Heckman** (with Joseph E. Keller,
  Thomas J. Hughes) — SPI counsel, who drafted the filings and choreographed the FDA approach.
- **The scientist:** **Dr. John P. ("Jack") Frawley, Chief Toxicologist, Hercules.**
- **Industry toxicology hands:** **W. A. Knapp** (Allied Chemical), **Kenneth Morgareidge** (Food & Drug
  Research Labs), **Carrol S. Weil** (Mellon Institute).
- **FDA actors:** **Dr. W. H. Summerson** (Director, Bureau of Science), **Lessel L. Ramsey** (Deputy/
  Assistant Director, Bureau of Science — later author of the FDA "Ramsey Proposal"), Associate
  Commissioner **J. Kenneth Kirk**, **Fred J. Delmore** (Bureau of Voluntary Compliance), Commissioners
  **James Goddard** then **Herbert Ley**, Hearing Clerk **Beryl McCullar.**
- **Trade press:** *Food Chemical News* (eds. Louis Rothschild Jr., Raymond [Newton]) — the campaign's
  scoreboard, repeatedly reprinted to the committees by Keller & Heckman.

## 2. Phase 1 — Launch (Sept 1966 → Jan 1967)
- **14 Sep 1966 — the debut.** Frawley reads **"Toxicological Evaluation of Migratory Food Additives"** at
  the ACS Symposium on Safety Evaluation of Coatings and Plastics for Food Packaging, New York; 143
  chronic studies; the conclusion that any component **"present in the article or its coating at a level
  not exceeding 0.2% by weight is generally recognized as safe"** (`…0orpG2Q7`, ASI-PR; his "denying the
  existence of zero" line appears here).
- **13–14 Dec 1966 — first FDA contact.** SPI convened a **Special Meeting with FDA** (Ramsey, McLoughlin)
  at the Shoreham Hotel, supplying **16 prepared questions in advance**; Question 3 teed up the Frawley
  thesis (`…3eM2j552`). Allied's **W. A. Knapp** reported candidly afterward: *"the writer gained the
  impression that FDA wanted migration data whether or not the migrant constituted any risk to public
  health"* (`…zdMLyLZa`, 1966-12-20, ASI-PR).
- **25–26 Jan 1967 — BIBRA.** Frawley delivers the mature version in London (published *Fd Cosmet
  Toxicol* 5:293–308), telling the audience FDA **"authorized me to tell you that they are giving it
  serious consideration"** (`…Ne9DgGn7`, `…qdozKJ6e`).

## 3. Phase 2 — Industry mobilization (1967)
- **25 Jan 1967 — early FDA warmth.** MCA minutes record Associate Commissioner **J. Kenneth Kirk** said
  the proposal **"has much merit"** and **"referred Frawley's conclusion to the FDA Bureau of Science"**
  (`…DXaG0`). The MCA resolved to solicit member-company data to validate the 0.2% concept.
- **Feb–Jun 1967 — building the dossier.** Both committees gather supporting data. Frawley's **17 Mar 1967**
  letter asks members for unpublished 2-year chronic studies and migration data (`…qkgDO`); he notes
  *"the concept might be adopted in the European countries before anything is done in the U.S."* Allied's
  Knapp supplies chronic-feeding data (`…3NeeR4XZ`, 1967-06-13).
- **20 Sep 1967 — the legal machine forms.** SPI creates a **Procedural Regulations Subcommittee** (Heckman
  coordinator; Knapp/Allied, Miller/Hercules, Hanavan/DuPont) and plans to remind **Commissioner Goddard**
  of the Kirk discussions (`…x5DwB`).
- **Oct 1967 — the formal filing.** On **23 Oct 1967** Frawley files comments with the **HEW Hearing Clerk**
  proposing to amend **Section 121.2500** to exempt packaging substances used at **≤0.2% by weight (except
  heavy metals and pesticides)** (`…evvR1`, `…B6m47`). Eastman calls the 1966 ACS paper **"the brilliant
  Frawley paper"** (`…3eXr4j4v`, 1967-10-06). **Both associations then formally endorse it to FDA:** MCA on
  **3 Nov 1967** (Decker; "185 companies… >90% of U.S. basic chemical capacity," `…pZpLVm8N`) and **SPI on
  6 Nov 1967** (Heckman: *"the Society of the Plastics Industry hereby endorses the recommendation that
  Section 121.2500… be amended,"* `…wgmex`).

## 4. Phase 3 — The FDA National Conference & the showdown (Feb 1968) ★ *(your document)*
FDA's response to the mounting pressure was to convene the **National Conference on Indirect Food
Additives, 13–14 Feb 1968**, opened by Commissioner **Goddard**, with **Frawley slotted to present
"Toxicology of Indirect Food Additives"** (`…wjga43zZ`, agenda). Keller & Heckman told the SPI committee
the conference's purpose bluntly: **"to get a public airing of the complaints before there is a
Congressional hearing"** (`…nka82JKV`, 1968-01-08).

### ★ "Frawley Proposal Praised for 'Soundness,' Hit as 'Sheer Nonsense'"
That is the verbatim *Food Chemical News* headline (issue of **19 Feb 1968**, pp. 5–6), reprinted to the
SPI committee by Keller & Heckman — your document, local file **`1yes__1968__AlliedSignal__PolyvinylC__
Kza60dbJNXoEMZbe1v7QM7VxK`** (Bates **ASI-PR 0000576–0000577**). It reports the head-to-head between Frawley
and **Dr. W. H. Summerson, Director of FDA's Bureau of Science**, whose paper **"dealt almost solely with
the Frawley proposal."** The drama is that Summerson did *both* things at once:

- **The praise:** under questioning Summerson conceded **"soundness of certain portions of Dr. Frawley's
  thesis,"** allowed there is some **"unjustifiable expense"** in testing, promised FDA would provide a
  **"documented commentary,"** and forecast: **"Somewhere in between will be a position that both Dr.
  Frawley and FDA can live with."** He even granted the 0.2% → <0.1 ppm generalization (minus pesticides/
  heavy metals/carcinogens) **"has considerable appeal and some reliability on the basis of 'published'
  toxicity data."**
- **The "sheer nonsense":** *"much of what Frawley proposed for a 'single cut-off place' is 'sheer
  nonsense.'"* Summerson's scientific objection was **cancer latency**: because the *"'incubation' period…
  until… cancer occurs is often 10 years or more,"* retrospective detection is *"well nigh impossible,"* so
  *"we must require premarket testing."* He pointedly rebuked the industry posture — **"the proponent feels
  no food additive clearance is necessary because he has no knowledge of any bad effects from his
  product"** — and **denied that the past 10 years of testing had been "a waste of time and money,"** a
  direct rebuttal of Frawley's "negligible return on investment" thesis.
- **The split-the-difference dance:** Frawley argued it was **"just a matter of degree"** (FDA already
  accepted 0.01 ppm without tox work; he proposed 0.1 ppm) and urged a **"middle ground"**; **Delmore**
  (FDA) said the two sides were **"not too far apart"**; **Heckman** (SPI) called a "middle ground" *"a
  good place to start."*

So the document is the single best primary snapshot of what FDA's "serious consideration" actually was: a
public, contested negotiation in which the agency's chief scientist simultaneously legitimized the
proposal's premise and savaged its central device (the "single cut-off"), while signaling compromise.

### ★ NEW — the *Frawley side* of the same showdown, now in primary text
We now hold **Frawley's actual conference address**, printed as **"A Reasoned Approach to Regulation Based
on Toxicologic Considerations," *Food Drug Cosm. Law J.* 23(5):260–270 (May 1968)** (local PDF
`papers/food_drug_1968_v23_n5.pdf`; excerpt in `sources/Frawley_Reasoned-Approach_NationalConf_Feb1968_…md`).
So **both sides of 13 Feb 1968 are now documented from primary text** — Summerson's "sheer nonsense" paper
(above, via *Food Chem. News*) and the speech he was rebutting. Three things the Frawley text adds:
- **It corroborates the campaign from the podium.** Frawley publicly claimed **"twenty-four other
  toxicologists… supported this proposal in writing to the FDA"** and that this support, per his lawyers,
  itself made the uses "gras." That "24 letters to FDA" is the public face of the SPI/Allied Signal
  coordination traced in §§2–3 — the organized effort presented to FDA as spontaneous scientific consensus.
- **The financial driver, first-person:** "**I personally had spent over a million dollars of my
  Corporation's money** investigating the safety of food packaging materials… it was all wasted."
- **Title drift:** the SPI agenda (`…wjga43zZ`) billed his talk as "**Toxicology of Indirect Food
  Additives**"; FDCLJ printed it under the "Reasoned Approach" title — same paper, and confirms he is the
  scheduled "Frawley" of the agenda. His data base is now **245** chronic studies; the rule is pinned to
  **Reg. 121.2500(d)**.

## 5. Phase 4 — The FDA counter-proposal and the long negotiation (1968–69)
- **The FDA in-house counter.** Through 1968 FDA staff drifted toward its **own** threshold — exempt
  substances contributing **≤0.05 ppm (50 ppb)** — but, unlike Frawley, **conditioned on extraction
  studies.** SPI minutes call this *"a direct result of the much discussed 'Frawley concept'"* (`…JN2yv`,
  1968-04-17); the **"key difference"** counsel repeatedly flagged was that **"the Frawley recommendations
  would exempt substances… without the need for extraction studies"** (`…oea1Zq1`, 1969-05-13). This is the
  primary-document birth of the **"Ramsey Proposal"** (the 50-ppb FDA version later abandoned 3 Jun 1971).
- **The NAS lever.** Heckman reported to Miller that the **NAS/NRC Food Protection Committee** had approved
  **"Quantitative Guidelines for Toxicologically Insignificant Levels of Chemical Additives in Food"** — on
  which **"Frawley participated"** — endorsing <0.1 ppm as toxicologically insignificant, and that *"there
  is good reason to believe that the Food and Drug Administration will accept this basic principle"*
  (`…1gK5pMrr`, 1969-01-24; `…mbqOEvX`, 1969-02-06).
- **Inter-industry coordination.** When FDA issued a **"discussion draft notice of proposed rule making"**
  (May 1969), Miller and Heckman organized a cross-industry response: a **3 Jun 1969** Washington meeting
  convened with **Einar Wulfsberg (American Paper Institute)**, forming an **Inter-Industry Committee on
  Indirect Additives** that filed with FDA (Aug 1969) and wrote directly to **L. L. Ramsey** (`…oea1Zq1`;
  6/3, 8/27, 8/29 records). Monsanto's internal "FDA call report" (1969-11-25) and Knapp's memos-to-file
  (1970-02-03; 1970) track the back-channel.

## 6. Phase 5 — Stalemate, doctrine, and the long tail (1970–1972 →)
FDA never adopted either threshold; the campaign nonetheless ran on — DuPont's Hanavan circulating draft
regulations to Frawley (1970-02-09; 1970-08-11), Frawley corresponding with **Carrol Weil** of Mellon on
the short-vs-long-study methodology (1970-03-04), and the SPI/MCA committees still pressing in **1971–72**
(`…QJ6Ez` 1971; `…Va6X0` & `…DGyy` 1972; MCA→Miller 1972-08-17). By the mid-1970s the idea had hardened
into accepted doctrine abroad — a 1975 Japanese review cites the **"Frawley limiting value"** (0.1 mg/day)
by name (`…99R8Eq`). FDA finally abandoned the Ramsey 50-ppb version on **3 Jun 1971** as legally
unworkable; the concept was resurrected by **Rulis (1987)** and codified in the **1995 Threshold of
Regulation rule** (see Strands I & `07_TOXICDOCS_FINDINGS`).

## 7. What this adds to the dossier
1. **Strand I upgraded from inference to documentation.** The "serious consideration" Frawley cited in
   1967 is now a fully-dated, named negotiation — Kirk's "much merit," Summerson's "sheer nonsense," the
   FDA 0.05-ppm counter, the NAS lever, the inter-industry committee, Ramsey by name.
2. **The conflict of interest is structural, not incidental.** The proposal's author (Frawley) and the
   sponsoring industry committee's chairman (Miller) were **both Hercules men, in the same building** —
   and the whole apparatus (SPI, MCA, Keller & Heckman, *Food Chemical News*) existed to convert one
   employee's "common-sense" thesis into a self-exempting federal rule.
3. **It explains the GLP bitterness.** The 1981 manifesto's fury at regulators (`06_ANALYTIC_MEMO` §2.3)
   reads differently once you see that Frawley spent 1966–72 being told by FDA's own Bureau of Science
   chief that his central device was "sheer nonsense."

*Local source list: `toxicdocs/_campaign_records.json` (per-document date, author, quotes, Bates). The
four richest files are the SPI committee minutes (`…2NB` 1966, `…wgmex` 1967, `…qL0ea` 1969, `…85ZZ` 1972)
and your "Soundness/Sheer Nonsense" clipping (`…Kza60dbJ`, ASI-PR 0000576–77).*